Pfizer Inc. insider trading
PFEfinancial statementsForm 4 filings on EDGAR89 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 3 insiders at Pfizer Inc. bought $3M of stock in the open market, and 1 sold $83K. Officers and directors accounted for $3M of purchases and $83K of sales. The last reported transaction was an open-market buy by Bourla Albert on August 12, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 12, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $3MSold $83KAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
89 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Bourla Albert | Chairman & CEO, Director | open-market buy | 38,000 | $26.34 | $1M | 429,173 | Aug 12, 2026 |
| Aug 5, 2026 | Damico Jennifer B. | SVP & Controller | open-market sale | 3,278 | $25.40 | $83K | 28,611 | Aug 6, 2026 |
| Aug 5, 2026 | Blaylock Ronald E | Director | open-market buy | 39,231 | $25.46 | $999K | 66,938 | Aug 5, 2026 |
| Aug 5, 2026 | Buckley Mortimer J | Director | open-market buy | 37,632 | $25.52 | $960K | 37,632 | Aug 5, 2026 |
| Jun 9, 2026 | Damico Jennifer B. | SVP & Controller | open-market sale | 2,000 | $25.70 | $51K | 31,397 | Jun 10, 2026 |
| Mar 4, 2026 | Damico Jennifer B. | SVP & Controller | tax withholding | 826 | $26.62 | $22K | 32,934 | Mar 5, 2026 |
| Mar 3, 2026 | Damico Jennifer B. | SVP & Controller | award | 16,311 | $0.00 | — | 28,352 | Mar 5, 2026 |
| Mar 3, 2026 | Damico Jennifer B. | SVP & Controller | award | 5,408 | $0.00 | — | 33,760 | Mar 5, 2026 |
| Feb 27, 2026 | Damico Jennifer B. | SVP & Controller | tax withholding | 655 | $27.65 | $18K | 12,041 | Mar 3, 2026 |
| Feb 26, 2026 | McDermott Michael | Executive Vice President | tax withholding | 3,503 | $27.10 | $95K | 74,308 | Feb 27, 2026 |
| Feb 25, 2026 | Sahni Payal | Executive Vice President | tax withholding | 1,083 | $27.09 | $29K | 81,733 | Feb 27, 2026 |
| Feb 25, 2026 | Sahni Payal | Executive Vice President | tax withholding | 54,066 | $26.92 | $1M | 27,667 | Feb 27, 2026 |
| Feb 25, 2026 | Sahni Payal | Executive Vice President | option exercise | 56,888 | $33.82 | $2M | 82,816 | Feb 27, 2026 |
| Feb 25, 2026 | Lankler Douglas M | Executive Vice President | tax withholding | 116,811 | $26.92 | $3M | 163,177 | Feb 27, 2026 |
| Feb 25, 2026 | Lankler Douglas M | Executive Vice President | tax withholding | 2,198 | $27.09 | $60K | 279,988 | Feb 27, 2026 |
| Feb 25, 2026 | Lankler Douglas M | Executive Vice President | option exercise | 122,907 | $33.82 | $4M | 282,186 | Feb 27, 2026 |
| Feb 25, 2026 | Damico Jennifer B. | SVP & Controller | option exercise | 17,558 | $33.82 | $594K | 29,744 | Feb 27, 2026 |
| Feb 25, 2026 | Damico Jennifer B. | SVP & Controller | tax withholding | 16,687 | $26.92 | $449K | 12,696 | Feb 27, 2026 |
| Feb 25, 2026 | Damico Jennifer B. | SVP & Controller | tax withholding | 361 | $27.09 | $10K | 29,383 | Feb 27, 2026 |
| Feb 25, 2026 | Bourla Albert | Chairman & CEO, Director | tax withholding | 8,303 | $27.09 | $225K | 855,912 | Feb 27, 2026 |
| Feb 25, 2026 | Bourla Albert | Chairman & CEO, Director | option exercise | 491,626 | $33.82 | $17M | 864,215 | Feb 27, 2026 |
| Feb 25, 2026 | Bourla Albert | Chairman & CEO, Director | tax withholding | 467,241 | $26.92 | $13M | 388,671 | Feb 27, 2026 |
| Feb 25, 2026 | Fonseca Lidia | Executive Vice President | option exercise | 56,888 | $33.82 | $2M | 101,579 | Feb 27, 2026 |
| Feb 25, 2026 | Fonseca Lidia | Executive Vice President | tax withholding | 1,058 | $27.09 | $29K | 100,521 | Feb 27, 2026 |
| Feb 25, 2026 | Fonseca Lidia | Executive Vice President | tax withholding | 54,066 | $26.92 | $1M | 46,455 | Feb 27, 2026 |
| Feb 25, 2026 | McDermott Michael | Executive Vice President | tax withholding | 36,044 | $26.92 | $970K | 77,811 | Feb 27, 2026 |
| Feb 25, 2026 | McDermott Michael | Executive Vice President | tax withholding | 679 | $27.09 | $18K | 113,855 | Feb 27, 2026 |
| Feb 25, 2026 | McDermott Michael | Executive Vice President | option exercise | 37,925 | $33.82 | $1M | 114,534 | Feb 27, 2026 |
| Feb 25, 2026 | Boshoff Christoffel | President, R&D | tax withholding | 6,833 | $27.09 | $185K | 161,379 | Feb 27, 2026 |
| Feb 25, 2026 | Boshoff Christoffel | President, R&D | award | 13,383 | $0.00 | — | 168,212 | Feb 27, 2026 |
| Feb 23, 2026 | Boshoff Christoffel | President, R&D | tax withholding | 816 | $27.06 | $22K | 154,829 | Feb 24, 2026 |
| Feb 23, 2026 | Damico Jennifer B. | SVP & Controller | tax withholding | 419 | $27.06 | $11K | 12,186 | Feb 24, 2026 |
| Jan 30, 2026 | Boshoff Christoffel | President, R&D | tax withholding | 12,887 | $26.44 | $341K | 155,645 | Feb 2, 2026 |
| Mar 4, 2025 | Damico Jennifer B. | SVP & Controller | award | 5,583 | $0.00 | — | 14,350 | Mar 6, 2025 |
| Mar 4, 2025 | Damico Jennifer B. | SVP & Controller | open-market sale | 2,500 | $25.93 | $65K | 11,850 | Mar 6, 2025 |
| Feb 27, 2025 | Damico Jennifer B. | SVP & Controller | tax withholding | 749 | $26.10 | $20K | 29,761 | Mar 6, 2025 |
| Feb 27, 2025 | Damico Jennifer B. | SVP & Controller | tax withholding | 553 | $26.10 | $14K | 30,510 | Mar 3, 2025 |
| Feb 27, 2025 | Damico Jennifer B. | SVP & Controller | tax withholding | 20,994 | $26.06 | $547K | 9,516 | Mar 3, 2025 |
| Feb 27, 2025 | Damico Jennifer B. | SVP & Controller | option exercise | 22,416 | $31.31 | $702K | 31,063 | Mar 3, 2025 |
| Feb 27, 2025 | Boshoff Christoffel | President, R&D | tax withholding | 8,909 | $26.10 | $233K | 163,238 | Mar 3, 2025 |
| Feb 27, 2025 | Boshoff Christoffel | President, R&D | award | 17,450 | $0.00 | — | 172,147 | Mar 3, 2025 |
| Feb 27, 2025 | Susman Sally | Executive Vice President | option exercise | 85,182 | $31.31 | $3M | 250,866 | Mar 3, 2025 |
| Feb 27, 2025 | Susman Sally | Executive Vice President | tax withholding | 2,178 | $26.10 | $57K | 248,688 | Mar 3, 2025 |
| Feb 27, 2025 | Susman Sally | Executive Vice President | tax withholding | 79,779 | $26.06 | $2M | 168,909 | Mar 3, 2025 |
| Feb 27, 2025 | Sahni Payal | Executive Vice President | tax withholding | 17,846 | $26.06 | $465K | 25,928 | Mar 3, 2025 |
| Feb 27, 2025 | Sahni Payal | Executive Vice President | option exercise | 19,054 | $31.31 | $597K | 44,242 | Mar 3, 2025 |
| Feb 27, 2025 | Sahni Payal | Executive Vice President | tax withholding | 468 | $26.10 | $12K | 43,774 | Mar 3, 2025 |
| Feb 27, 2025 | McDermott Michael | Executive Vice President | option exercise | 48,419 | $31.31 | $2M | 122,413 | Mar 3, 2025 |
| Feb 27, 2025 | McDermott Michael | Executive Vice President | tax withholding | 1,108 | $26.10 | $29K | 121,305 | Mar 3, 2025 |
| Feb 27, 2025 | McDermott Michael | Executive Vice President | tax withholding | 45,347 | $26.06 | $1M | 75,958 | Mar 3, 2025 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Bourla Albert | Chairman & CEO, Director | Aug 12, 2026 | open-market buy | 429,173 | $1M (1) | — | — |
| Blaylock Ronald E | Director | Aug 5, 2026 | open-market buy | 66,938 | $999K (1) | — | — |
| Buckley Mortimer J | Director | Aug 5, 2026 | open-market buy | 37,632 | $960K (1) | — | — |
| Damico Jennifer B. | SVP & Controller | Aug 5, 2026 | open-market sale | 28,611 | — | $135K (2) | 0 of 2 |
| Boshoff Christoffel | President, R&D | Feb 25, 2026 | tax withholding | 161,379 | — | — | — |
| McDermott Michael | Executive Vice President | Feb 26, 2026 | tax withholding | 74,308 | — | — | — |
| Sahni Payal | Executive Vice President | Feb 25, 2026 | tax withholding | 81,733 | — | — | — |
| Lankler Douglas M | Executive Vice President | Feb 25, 2026 | tax withholding | 163,177 | — | — | — |
| Fonseca Lidia | Executive Vice President | Feb 25, 2026 | option exercise | 101,579 | — | — | — |
| Susman Sally | Executive Vice President | Feb 27, 2025 | option exercise | 250,866 | — | — | — |
Questions
Are Pfizer Inc. insiders buying or selling?
Over the twelve months to November 1, 2026, 1 insider at Pfizer Inc. sold $135K of stock in the open market, all by officers and directors, and 3 insiders bought $3M, all by officers and directors. Net, insiders bought $3M. Only open-market purchases and sales are counted.
Who sold the most Pfizer Inc. stock in the last year?
Damico Jennifer B. (SVP & Controller) sold $135K in 2 open-market sales over the twelve months to November 1, 2026.
Do Pfizer Inc. executives sell under 10b5-1 plans?
0 of the 2 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Pfizer Inc.
- Pfizer Inc. financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.